Accrued Expenses

6 Months Ended

Jun. 30, 2025

Accrued Expenses [Abstract]

Accrued Expenses

(5)

Accrued Expenses

Accrued expenses included the following:

		June 30,	December 31,
		2025	2024
Incentive and other compensation costs	$	369,117	650,768
Clinical trial costs		327,906	354,762
Accrued interest		248,863	44,525
Director fees		71,250	70,000
Other		35,616	30,994
Accrued expenses	$	1,052,752	1,151,049